These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


152 related items for PubMed ID: 3139758

  • 21. Analyses of prostaglandin D2 metabolites in urine: comparison between enzyme immunoassay and negative ion chemical ionisation gas chromatography-mass spectrometry.
    O'Sullivan S, Mueller MJ, Dahlén SE, Kumlin M.
    Prostaglandins Other Lipid Mediat; 1999 May; 57(2-3):149-65. PubMed ID: 10410385
    [Abstract] [Full Text] [Related]

  • 22. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils.
    Raible DG, Schulman ES, DiMuzio J, Cardillo R, Post TJ.
    J Immunol; 1992 Jun 01; 148(11):3536-42. PubMed ID: 1588043
    [Abstract] [Full Text] [Related]

  • 23. PGD2 is transformed by human coronary arteries to 9 alpha, 11 beta-PGF2, which contracts human coronary artery rings.
    Roberts LJ, Seibert K, Liston TE, Tantengco MV, Robertson RM.
    Adv Prostaglandin Thromboxane Leukot Res; 1987 Jun 01; 17A():427-9. PubMed ID: 2959090
    [No Abstract] [Full Text] [Related]

  • 24. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid.
    Morrow JD, Parsons WG, Roberts LJ.
    Prostaglandins; 1989 Aug 01; 38(2):263-74. PubMed ID: 2475889
    [Abstract] [Full Text] [Related]

  • 25. Cholinergic-mediated bronchoconstriction induced by prostaglandin D2, its initial metabolite 9 alpha,11 beta-PGF2, and PGF2 alpha in asthma.
    Beasley R, Varley J, Robinson C, Holgate ST.
    Am Rev Respir Dis; 1987 Nov 01; 136(5):1140-4. PubMed ID: 2960256
    [Abstract] [Full Text] [Related]

  • 26. Stereospecific conversion of prostaglandin D2 to (5Z,13E)-(15S)-9 alpha-11 beta,15-trihydroxyprosta-5,13-dien-1-oic acid (9 alpha,11 beta-prostaglandin F2) and of prostaglandin H2 to prostaglandin F2 alpha by bovine lung prostaglandin F synthase.
    Watanabe K, Iguchi Y, Iguchi S, Arai Y, Hayaishi O, Roberts LJ.
    Proc Natl Acad Sci U S A; 1986 Mar 01; 83(6):1583-7. PubMed ID: 3456602
    [Abstract] [Full Text] [Related]

  • 27. Stimulation of prostaglandin synthesis in cultured liver cells by CCl4.
    Johnston DE, Kroening C.
    Hepatology; 1996 Sep 01; 24(3):677-84. PubMed ID: 8781342
    [Abstract] [Full Text] [Related]

  • 28. Reduction of prostaglandin D2 to 9 alpha,11 beta-prostaglandin F2 by a human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isozyme.
    Ohara H, Nakayama T, Deyashiki Y, Hara A, Miyabe Y, Tsukada F.
    Biochim Biophys Acta; 1994 Nov 17; 1215(1-2):59-65. PubMed ID: 7948008
    [Abstract] [Full Text] [Related]

  • 29. Topical benzoic acid induces the increased biosynthesis of prostaglandin D2 in human skin in vivo.
    Downard CD, Roberts LJ, Morrow JD.
    Clin Pharmacol Ther; 1995 Apr 17; 57(4):441-5. PubMed ID: 7712673
    [Abstract] [Full Text] [Related]

  • 30. Renal response to 9 alpha, 11 beta-prostaglandin F2 in the rat.
    Stier CT, Roberts LJ, Wong PY.
    J Pharmacol Exp Ther; 1987 Nov 17; 243(2):487-91. PubMed ID: 3479549
    [Abstract] [Full Text] [Related]

  • 31. Determination of 6-keto-PGF1 alpha, TXB2, PGF2 alpha, PGE2, PGD2 in human blood: a comparison of RIA and GC-NICI-MS.
    Weber C, Beetens J, van de Wiele R, Beile A, Lohkamp R, de Clerck F, Höller M.
    Prog Clin Biol Res; 1989 Nov 17; 301():113-7. PubMed ID: 2798442
    [No Abstract] [Full Text] [Related]

  • 32. 15R-methyl-prostaglandin D2 is a potent and selective CRTH2/DP2 receptor agonist in human eosinophils.
    Monneret G, Cossette C, Gravel S, Rokach J, Powell WS.
    J Pharmacol Exp Ther; 2003 Jan 17; 304(1):349-55. PubMed ID: 12490611
    [Abstract] [Full Text] [Related]

  • 33. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T, Satoh H, Togoh M, Taniguchi S, Hashimoto Y, Kurokawa K.
    J Cell Physiol; 1996 Nov 17; 169(2):401-9. PubMed ID: 8908208
    [Abstract] [Full Text] [Related]

  • 34. Transformation of prostaglandin D2 to 9 alpha, 11 beta-(15S)-trihydroxyprosta-(5Z,13E)-dien-1-oic acid (9 alpha, 11 beta-prostaglandin F2): a unique biologically active prostaglandin produced enzymatically in vivo in humans.
    Liston TE, Roberts LJ.
    Proc Natl Acad Sci U S A; 1985 Sep 17; 82(18):6030-4. PubMed ID: 3862115
    [Abstract] [Full Text] [Related]

  • 35. Agonist and antagonist effects of 15R-prostaglandin (PG) D2 and 11-methylene-PGD2 on human eosinophils and basophils.
    Cossette C, Walsh SE, Kim S, Lee GJ, Lawson JA, Bellone S, Rokach J, Powell WS.
    J Pharmacol Exp Ther; 2007 Jan 17; 320(1):173-9. PubMed ID: 17041009
    [Abstract] [Full Text] [Related]

  • 36. Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha.
    Pratico D, Lawson JA, FitzGerald GA.
    J Biol Chem; 1995 Apr 28; 270(17):9800-8. PubMed ID: 7730359
    [Abstract] [Full Text] [Related]

  • 37. Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells.
    Schleimer RP, Schulman ES, MacGlashan DW, Peters SP, Hayes EC, Adams GK, Lichtenstein LM, Adkinson NF.
    J Clin Invest; 1983 Jun 28; 71(6):1830-5. PubMed ID: 6134755
    [Abstract] [Full Text] [Related]

  • 38. Profile of prostanoid release following antigen challenge in vivo in the skin of man.
    Massey WA, Hubbard WC, Liu MC, Kagey-Sobotka A, Cooper P, Lichtenstein LM.
    Br J Dermatol; 1991 Dec 28; 125(6):529-34. PubMed ID: 1760357
    [Abstract] [Full Text] [Related]

  • 39. Leptin Elicits In Vivo Eosinophil Migration and Activation: Key Role of Mast Cell-Derived PGD2.
    Amorim NRT, Souza-Almeida G, Luna-Gomes T, Bozza PT, Canetti C, Diaz BL, Maya-Monteiro CM, Bandeira-Melo C.
    Front Endocrinol (Lausanne); 2020 Dec 28; 11():572113. PubMed ID: 33117286
    [Abstract] [Full Text] [Related]

  • 40. Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.
    Hardy CC, Holgate ST, Robinson C.
    Br J Pharmacol; 1986 Mar 28; 87(3):563-8. PubMed ID: 3467804
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.